![David E. Martin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David E. Martin
Directeur Général chez TrippBio, Inc.
Postes actifs de David E. Martin
Sociétés | Poste | Début | Fin |
---|---|---|---|
TrippBio, Inc.
![]() TrippBio, Inc. Miscellaneous Commercial ServicesCommercial Services TrippBio, Inc. engages in biotechnology industry. The company is headquartered in Jacksonville, FL. | Directeur Général | 25/05/2021 | - |
President | 25/05/2021 | - |
Historique de carrière de David E. Martin
Anciens postes connus de David E. Martin
Sociétés | Poste | Début | Fin |
---|---|---|---|
Panacos Pharmaceuticals, Inc. /Old/
![]() Panacos Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Panacos Pharmaceuticals is engaged in the discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos’ proprietary discovery technologies focus on novel targets in the virus life cycle, including virus fusion and virus maturation, the first and last steps of viral infection | Corporate Officer/Principal | 01/01/2001 | 01/03/2005 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2001 | 01/01/2001 |
PharmaResearch Corp
![]() PharmaResearch Corp Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., PharmaResearch Corp is a company that provides pharmaceutical development and research services. The company is based in Wilmington, NC. The company was founded by James Douglas Esinhart. PharmaResearch was acquired by Inveresk Research Group, Inc., part of Charles River Laboratories International, Inc. from October 20, 2004 on July 29, 2003 for $37.10 million. | Corporate Officer/Principal | 01/01/1997 | 01/01/1999 |
Tobira Therapeutics, Inc. /Old/
![]() Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Conseiller Juridique Général | 26/02/2010 | - |
PANACOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2005 | - |
Formation de David E. Martin
St. Joseph's University | Masters Business Admin |
USC School of Pharmacy | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Opérationnelle
Corporate Officer/Principal | 4 |
Masters Business Admin | 1 |
General Counsel | 1 |
Sectorielle
Health Technology | 4 |
Commercial Services | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
PANACOS PHARMACEUTICALS, INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Entreprise privées | 4 |
---|---|
Panacos Pharmaceuticals, Inc. /Old/
![]() Panacos Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Panacos Pharmaceuticals is engaged in the discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos’ proprietary discovery technologies focus on novel targets in the virus life cycle, including virus fusion and virus maturation, the first and last steps of viral infection | Commercial Services |
PharmaResearch Corp
![]() PharmaResearch Corp Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., PharmaResearch Corp is a company that provides pharmaceutical development and research services. The company is based in Wilmington, NC. The company was founded by James Douglas Esinhart. PharmaResearch was acquired by Inveresk Research Group, Inc., part of Charles River Laboratories International, Inc. from October 20, 2004 on July 29, 2003 for $37.10 million. | Commercial Services |
Tobira Therapeutics, Inc. /Old/
![]() Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Health Technology |
TrippBio, Inc.
![]() TrippBio, Inc. Miscellaneous Commercial ServicesCommercial Services TrippBio, Inc. engages in biotechnology industry. The company is headquartered in Jacksonville, FL. | Commercial Services |
- Bourse
- Insiders
- David E. Martin
- Expérience